Confirmed speakers include:


 Avan Sayer

Professor Avan Aihie Sayer, Newcastle University, UK

Professor Sayer is Director of the NIHR Newcastle Biomedical Research Centre, an NIHR Senior Investigator, and William Leech Professor of Geriatric Medicine at Newcastle University UK. She works as an Honorary Consultant in Older People’s Medicine at Newcastle Hospitals. She is at the forefront of the field of Geriatrics and Gerontology internationally for her research on the ageing syndromes of sarcopenia, frailty and multimorbidity. Her focus is on translating mechanistic understanding into improved diagnosis, treatment and prevention across the life course. An important remit is capacity building across disciplines in the exciting new field of translational ageing research.



 Peggy Cawthon

Dr Peggy Cawthorn, University of California San Francisco, USA

Dr Cawthon received a doctorate in epidemiology from University of California, Berkeley. Dr Cawthon's current research interests include maintaining mobility in old age;sarcopenia (age-related muscle loss); frailty; the decline of physical function with age; and osteoporosis, particularly in older men. Dr Cawthon leads large, multi-center observational studies. She co-led the recent Sarcopenia Definitions and Outcomes Consortium (SDOC) to refine sarcopenia definitions. Finally, she also oversees the Statistical Analyst Group at the San Francisco Coordinating Center.



Professor Lynne Cox, University of Oxford, UK

Lynne Cox is a biogerontologist at the University of Oxford and is head of the lab of Ageing and Cell Senescence at the Department of Biochemistry. She holds an MA and PhD from the University of Cambridge, and as a post-doctoral scientist in Dundee, helped develop initial IP for the spin-out company Cyclacel. She is an Associate Professor at the Department of Biochemistry, the George Moody Fellow and Tutor in Biochemistry at Oriel College, Oxford, a Trustee of the British Society for Research on Ageing, Fellow of the Royal Society of Biology, co-founder of the Oxford Ageing Network, and strategic board member for the Ageing Research Collaborative Hub in Oxford. In 2014, she received the US Glenn Foundation award for research into the biological mechanisms of ageing. She serves on the strategic advisory board of the All-Party Parliamentary Group for Longevity, and is co-chair of the Special Interest Group in Ageing Biology of the European Geriatric Medicine Society. 


Alfonso Cruz-Jentoft

Professor Alfonso Cruz-Jentoft, Hospital Universitario Ramón y Cajal (IRYCIS), Madrid, Spain

Specialist in Geriatric Medicine. Chair of the Geriatric Department of the Hospital Universitario Ramón y Cajal and the Geriatrics research group of the hospital’s research institute (IRyCIS) in Madrid, Spain. Professor of Geriatrics at the Universidad Europea de Madrid. Chair of the Spanish National Board of Geriatrics.

Past President of the European Geriatric Medicine Society (EuGMS), now member of its Academic Board and Editor-in-Chief of European Geriatric Medicine, the official journal of the EuGMS. Also part of the International Editorial Board of some major geriatric journals (Age Ageing, J Am Geriatr Soc, JAMDA, JNHA, Aging Clin Exp Res).​ Coordinator of the European Working Group on Sarcopenia in Older People (EWGSOP) and member of the WHO Clinical Consortium on Healthy Ageing. Member of the Scientific Advisory Board of ESCEO and IOF.  



Professor Robin Daly, Deakin University, Australia 

Professor Robin Daly holds the position of Chair in Exercise and Ageing, co-leads the Preventing and Managing Chronic Diseases research domain and is Head of the Musculoskeletal Health and Mobility group within the Institute for Physical Activity and Nutrition (IPAN) at Deakin University, Melbourne, Australia. His research focuses on conducting clinical and translational randomized controlled trials to understand how exercise and nutritional approaches can prevent and manage diseases such as osteoporosis, sarcopenia, falls and fractures, type 2 diabetes, certain cancers and cognitive related disorders. His work has led to the implementation of evidence‐based, community exercise programs and nutritional products to optimise musculoskeletal health, body composition and manage type 2 diabetes. He is also interested in the role of digital technology as a model of service delivery for the prescription of evidence-based exercise (and self-management programs) for older adults and those with chronic conditions. He is immediate-Past President of the Australian and New Zealand Society for Sarcopenia and Frailty Research (ANZSSFR) and a Fellow of Sports Medicine Australia and a Fellow of the American Society for Bone and Mineral Research.

Richard Dodds

Dr Richard Dodds, Newcastle University, UK

Richard Dodds is an intermediate clinical fellow at Newcastle University and an honorary consultant geriatrician at Newcastle upon Tyne Hospitals NHS Foundation Trust. He previously completed a Wellcome Trust PhD fellowship on the epidemiology of changes in muscle strength across the life course and continues to use data from several different cohorts to investigate this area. 

He is a current student of the European Academy for Medicine of Ageing and he is secretary of the UK Association for Academic Geriatric Medicine.

He tweets @dodds_rm 



Miranda Grounds

Professor Miranda Grounds, University of Western Australia, Australia 

For over 40 years the research of Professor Miranda Grounds based at the University of Western Australia has focussed on skeletal muscle biology, using mainly in vivo mouse models to investigate factors controlling the post-natal growth, muscle mass maintenance, damage and regeneration of normal and diseased muscles including age-related loss of muscle mass and function (sarcopenia) and muscular dystrophies. This research encompasses myogenesis, stem cells, growth factors, transplantation, inflammation, oxidative stress and the extracellular matrix, with potential applications to tissue engineering, muscular dystrophies and sarcopenia. A major focus is to strengthen pre-clinical research studies, in order to accelerate efficient development of clinical therapies, working in close collaboration with the international TreatNMD network



Thomas Jackson

Dr Thomas Jackson, University of Birmingham, UK

Thomas qualified in Medicine in 2003, from Guy’s, Kings and St Thomas’ School of Medicine in London.  After junior doctor jobs in London he moved to Birmingham to undertake specialist training in geriatric medicine, and obtained a PhD in 2016.  His PhD was on pragmatic methods to identify dementia in older people with delirium and the affects of clinical subtypes and inflammatory profiles of delirium on outcomes.

Dr Jackson currently works as a clinical academic geriatrician in the Institute of Inflammation and Ageing at the University of Birmingham.  His research interests include the immune-inflammatory basis of delirium,  as well as work understanding how our ageing immune system may drive frailty and sarcopenia.  He is an NIHR West Midlands CRN Research Scholar, and was recently awarded the British Geriatrics Society Rising Star Research award.  


 Michael Kjaer

Professor Michael Kjaer, University of Copenhagen, Denmark

Michael Kjaer is Rheumatologist and Heads the Institute of Sports Medicine, Bispebjerg Hospital and is a Board member of Centre for Healthy Ageing, Faculty of Health and Medical Sciences, and is a Professor in Sports Medicine at University of Copenhagen. His research area is within the influence of physical activity upon skeletal muscle and connective tissue in relation ageing and tissue injury.



John Morely

Professor John Morley, Saint Louis University, USA

John E. Morley, MB, BCh, is Professor at Saint Louis University School of Medicine.  He retired as the Director of the Division of Geriatric Medicine on June 30, 2019 after 30 years of service. He has edited more than 20 books, and published more than 1400 papers, with major research emphases on the role of neuropeptides in the modulation of hormonal responses and behavior and on nutrition, geriatric assessments, sarcopenia, cachexia diabetes and hormones in the elderly. 


Sian Robinson

Professor Sian Robinson, Newcastle University, UK

Sian Robinson is nutritional epidemiologist. Her main interests are in lifecourse influences of diet and lifestyle on health in later life, focusing particularly on inequalities in health in older age.  She previously worked on large UK birth cohort studies, based at the University of Southampton, before joining the AGE Research Group in December 2018.  She also has interests in nutrition policy and is a member of the Scientific Advisory Committee on Nutrition that advises Public Health England and other government organisations.


Tea Shavlakadeze

Dr Tea Shavlakadze, Regeneron Pharmaceuticals, New York, USA

Dr Tea Shavlakadze is Director at the Aging/Age-Associated Disorders at Regeneron Pharmaceuticals (New York, USA). Her research focuses on drug discovery aimed at targeting pathways that create a permissive environment for, or directly induce, age-related changes and diseases. From 2014-2020, Dr Shavlakadze was an investigator at Novartis Institutes of Biomedical Research (Cambridge, USA) where she focused on discovery and perturbation of age-related signalling pathways to treat age-related disorders. Prior to joining the industry, Dr Shavlakadze obtained her PhD (2001-2005) from the University of Western Australia (UWA) and was then an Associate Professor at UWA from 2005 to 2014. At UWA, she conducted independent research on factors that contribute to the loss of skeletal muscle mass and function and established a broad biomedical research program on skeletal muscle aging.



Professor Claire Stewart, Liverpool John Moores University, UK

Claire Stewart is employed at Liverpool John Moores University in the Research Institute for Sport and Exercise Sciences as a Professor of stem cell biology, with 25 years post-PhD experience. With a degree in Developmental Biology (University of Glasgow), a PhD in large animal physiology, biochemistry and endocrinology (The Babraham Institute, Cambridge and the University of London) and post-doctoral expertise in stem cell and molecular biology (Washington University Medical School, St Louis and the University of Bristol), she is one of only a handful of people who has extensive and long term training and experience in cell and molecular health physiology.  This enables an ability to design mechanistic questions with relevant physiological applications.  To elucidate the mechanisms underpinning skeletal muscle adaptation, she was one of the first in the world to report the anti-apoptotic roles of the insulin-like growth factors (IGFs) in muscle cells and amongst the first internationally to develop/report on the use of adult human muscle and childhood adipose stem cells as models to investigate the impact of age and disease on their behaviour. These studies led to an on-going interest in the roles of the IGF family and cytokine interactions in skeletal muscle stem cells isolated from human subjects across the lifespan from children to adults in health and disease. These studies illustrate that cells retain an intrinsic memory of the environment from which they were derived, an exciting area which underpins some of her ongoing research interests to date. In addition to research and teaching interests and of particular relevance to this meeting is the fact that she is the appointed Chair of the British Society for Research on Ageing.


Miles Witham

Professor Miles Witham, Newcastle University, UK

Miles Witham is Professor of Trials for Older People in the NIHR Newcastle Biomedical Research Centre, Newcastle University, and is National Speciality Lead for the NIHR Ageing Clinical Research Network. He also works as a consultant Geriatrician working in both primary and secondary care. His research aims to improve physical function and quality of life for older people, using a wide range of interventions, including pharmacological agents, nutrition, exercise and strategies of care. 

Professor Witham is developing a programme of trials both to test interventions targeting sarcopenia and physical frailty, but also to improve the way that we design and run trials for older people. He is also co-founder on the British Geriatrics Society Sarcopenia and Frailty Research Group, which aims to both support research and ensure that the results influence clinical practice. 

He tweets at @OlderTrialsProf